Grading of gastric foveolar-type dysplasia in Barrett's esophagus

Modern Pathology

Volumn 23, Issue 1, 2010, Pages 1-11

  Mahajan, Dipti ^a   Bennett, Ana E ^a   Liu, Xiaobo ^a   Bena, James ^a   Bronner, Mary P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Barrett's esophagus; Gastric type dysplasia; High grade dysplasia; Intestinal type dysplasia; Intra mucosal carcinoma; Low grade dysplasia

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CELL NUCLEUS; CELL POLARITY; CELL SIZE; CELL STRUCTURE; CYTOPLASM; DYSPLASIA; ESOPHAGUS BIOPSY; FEMALE; FOLLOW UP; GOBLET CELL; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NUCLEOLUS; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREVALENCE;

EID: 73949135640     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.147     Document Type: Article

References (22)

1. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379-388.
2. Cameron AJ. Barrett's esophagus: does the incidence of adenocarcinoma matter? Am J Gastroenterol 1997;92:193-194.
3. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-859.
4. Rucker-Schmidt RL, Sanchez CA, Blount PL, et al. Nonadenomatous dysplasia in Barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study. Am J Surg Pathol 2009;33:886-893.
5. Odze RD. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 2006;59:1029-1038.
6. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368-378.
7. Yachimski P, Nishioka NS, Richards E, et al. Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol 2008;6:1206-1211.
8. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008;103:788-797.
9. Downs-Kelly E, Mendelin JE, Bennett AE, et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol 2008;103:2333-2340.
10. Ireland AP, Clark GW, DeMeester TR. Barrett's esophagus. The significance of p53 in clinical practice. Ann Surg 1997;225:17-30.
11. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocar-cinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-312.
12. Hornick JL, Odze RD. Neoplastic precursor lesions in Barrett's esophagus. Gastroenterol Clin North Am 2007;36:775-796.
13. Abraham SC, Montgomery EA, Singh VK, et al. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 2002;26:1276-1285.
14. Abraham SC, Park SJ, Lee JH, et al. Genetic alterations in gastric adenomas of intestinal and foveolar pheno-types. Mod Pathol 2003;16:786-795.
15. Park do Y, Srivastava A, Kim GH, et al. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. Am J Surg Pathol 2008;32:524-533.
16. Park do Y, Lauwers GY. Gastric polyps: classification and management. Arch Pathol Lab Med 2008, 132: 633-640.
17. Srivastava A, Lauwers GY. Gastric epithelial dysplasia: the Western perspective. Dig Liver Dis 2008;40: 641-649.
18. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histologic criteria for grading. Hum Pathol 1997;28:127-133.
19. Lauwers GY, Srivastava A. Gastric preneoplastic lesions and epithelial dysplasia. Gastroenterol Clin North Am 2007;36:813-829.
20. Bronner MP, Overholt BF, Taylor SL, et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dys-plasia. Gastroenterology 2009;136:56-64.
21. Asthana N, Mandich D, Ligato S. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus. Am J Surg Pathol 2008;32:1581-1585.
22. Chandrasoma P. Controversies of the cardiac mucosa and Barrett's oesophagus. Histopathology 2005;46: 361-873.